Opus Genetics, Inc. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
Opus Genetics, Inc. (IRD) had Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) of $73.00 thousand as of 2014-08-01, per its 10-K filed 2015-03-16.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValueIssuedForCash · last filed 2015-03-16
- 2014-08-01: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) $73.00K.
- 2014-02-10: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 0 month $336.00K.
- 2013-10-10: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) $106.00K; Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 0 month $106.00K.
- 2013-08-31: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 1 month $63.60K.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 0 month | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 1 month |
|---|---|---|---|
| 2014-08-01 | $73.00K 10-K · filed 2015-03-16 | ||
| 2014-02-10 | $336.00K 10-K · filed 2015-03-16 | ||
| 2013-10-10 | $106.00K 10-K · filed 2015-03-16 | $106.00K 10-K · filed 2014-03-21 | |
| 2013-08-31 | $63.60K 10-K · filed 2014-03-21 | ||
| 2013-08-01 | $63.60K 10-K · filed 2015-03-16 | ||
| 2013-06-10 | $100.00K 10-K · filed 2015-03-16 | $100.00K 10-K · filed 2014-03-21 | |
| 2013-05-10 | $37.20K 10-K · filed 2015-03-16 | $37.20K 10-K · filed 2014-03-21 | |
| 2012-12-07 | $750.00K 10-Q · filed 2013-08-12 | ||
| 2011-01-19 | $3.95M 10-Q · filed 2013-08-12 | $3.95M 10-Q · filed 2012-08-08 | |
| 2009-09-21 | $3.50M 10-Q · filed 2013-08-12 | $3.50M 10-Q · filed 2012-08-08 | |
| 2001-05-10 | $1.00 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |